Side effects of efavirenz/emtricitabine/tenofovir (EFV+FTC+TDF, Viraday)
Efavirenz/emtricitabine/tenofovir (EFV+FTC+TDF, Viraday), as a compound antiretroviral drug, may cause some side effects during the treatment of HIV infection. It is important to note that the severity and incidence of side effects may vary among different patients. The following are some common side effects that may occur with efavirenz/emtricitabine/tenofovir:
1. Headache: Some patients may experience mild or moderate headache when starting efavirenz/emtricitabine/tenofovir.
2. Fatigue: Feeling tired and weak is one of the common side effects.
3. Nausea and vomiting: Some patients may experience nausea and vomiting in the early stages of treatment.
4. Diarrhea: During the use of efavirenz/emtricitabine/tenofovir, some patients may experience mild diarrhea symptoms.
7. Mental abnormalities: When using efavirenz (EFV), some patients may experience mental abnormalities, such as depression, anxiety, insomnia, etc.
It is important to note that most side effects are mild and temporary and disappear on their own after treatment has been ongoing for some time. However, if patients experience serious side effects or allergic reactions while taking efavirenz/emtricitabine/tenofovir, they should inform their doctor immediately and seek medical help.
Additionally, individual differences can cause different patients to respond differently to medications, so the occurrence and severity of side effects can vary from person to person. For patients who are taking efavirenz/emtricitabine/tenofovir, it is recommended to regularly report their physical conditions and side effects to their doctors so that doctors can monitor and adjust treatment plans in a timely manner.
Overall, the potential benefits of efavirenz/emtricitabine/tenofovir as highly effective anti-HIV therapies generally outweigh the possible side effects. When patients use efavirenz/emtricitabine/tenofovir, they should treat according to the doctor's advice and guidance, and follow the usage and dosage of the drug to ensure the best therapeutic effect and safety.
Efavirenz/emtricitabine/tenofovir (EFV+FTC+TDF, efavirenz/emtricitabine/tenofovir) is not currently on the market in China, so patients cannot purchase it domestically and need to purchase it through overseas purchasing channels. The cheaper ones abroad are mainly Indian generic drugs, which cost around 380 yuan.
1. Headache: Some patients may experience mild or moderate headache when starting efavirenz/emtricitabine/tenofovir.
2. Fatigue: Feeling tired and weak is one of the common side effects.
3. Nausea and vomiting: Some patients may experience nausea and vomiting in the early stages of treatment.
4. Diarrhea: During the use of efavirenz/emtricitabine/tenofovir, some patients may experience mild diarrhea symptoms.
5. Rash: Rash may be an uncommon side effect of efavirenz/emtricitabine/tenofovir, but may occur in some patients.
7. Mental abnormalities: When using efavirenz (EFV), some patients may experience mental abnormalities, such as depression, anxiety, insomnia, etc.
It is important to note that most side effects are mild and temporary and disappear on their own after treatment has been ongoing for some time. However, if patients experience serious side effects or allergic reactions while taking efavirenz/emtricitabine/tenofovir, they should inform their doctor immediately and seek medical help.
Additionally, individual differences can cause different patients to respond differently to medications, so the occurrence and severity of side effects can vary from person to person. For patients who are taking efavirenz/emtricitabine/tenofovir, it is recommended to regularly report their physical conditions and side effects to their doctors so that doctors can monitor and adjust treatment plans in a timely manner.
Overall, the potential benefits of efavirenz/emtricitabine/tenofovir as highly effective anti-HIV therapies generally outweigh the possible side effects. When patients use efavirenz/emtricitabine/tenofovir, they should treat according to the doctor's advice and guidance, and follow the usage and dosage of the drug to ensure the best therapeutic effect and safety.
Efavirenz/emtricitabine/tenofovir (EFV+FTC+TDF, efavirenz/emtricitabine/tenofovir) is not currently on the market in China, so patients cannot purchase it domestically and need to purchase it through overseas purchasing channels. The cheaper ones abroad are mainly Indian generic drugs, which cost around 380 yuan.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)